Improvement of dermatological symptoms in patients with Bachmann-Bupp syndrome using difluoromethylornithine treatment.

Afrin, Antara; Afshan, Tonia S; VanSickle, Elizabeth A; Michael, Julianne; Laarman, Rachel L; Bupp, Caleb P

Afrin, Antara; Afshan, Tonia S; VanSickle, Elizabeth A; Michael, Julianne; Laarman, Rachel L; Bupp, Caleb P.

Afiliação

Afrin A; College of Human Medicine, Michigan State University, Grand Rapids, Michigan, USA.
Afshan TS; Pediatric Residency Program, Spectrum Health/Michigan State University/Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.
VanSickle EA; Division of Allergy, Pulmonary, and Critical Care, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Michael J; Division of Medical Genetics and Genomics, Spectrum Health and Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.
Laarman RL; International Center for Polyamine Disorders, Grand Rapids, Michigan, USA.
Bupp CP; Division of Medical Genetics and Genomics, Spectrum Health and Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.

Pediatr Dermatol ; 40(3): 528-531, 2023.

Article em En | MEDLINE | ID: mdl-36443247

Assuntos

Eflornitina; Ornitina Descarboxilase; Estados Unidos; Humanos; Eflornitina/uso terapêutico; Ornitina Descarboxilase/genética; Inibidores da Ornitina Descarboxilase; Ornitina

Palavras-chave

alopecia; difluoromethylornithine; drug therapy; follicular cyst; ornithine decarboxylase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ornitina Descarboxilase / Eflornitina Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Pediatr Dermatol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google